Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefan Heitmeier

Showing results (21-30 of 44) with videos related to

Pageof 5
Sort By:
Investigative Radiology|April 11, 2025
Pharmacokinetics, Safety, and Dialyzability of Gadoquatrane in Patients With Impaired Renal Function: A Comprehensive Investigation Using Clinical Trial Data, Modeling and Simulation, and In Vitro DataTommaso Fadini, Gabriele Sutter, Stefan Klein, et al.
Journal of Neuroscience Research|December 31, 2016
Reduction of intracerebral hemorrhage by rivaroxaban after tPA thrombolysis is associated with downregulation of PAR-1 and PAR-2Ryuta Morihara, Toru Yamashita, Syoichiro Kono, et al.
Atherosclerosis|February 20, 2022
Effect of combining aspirin and rivaroxaban on atherosclerosis in miceSteven P Grover, Taylor Coughlin, Salma M Fleifil, et al.
Pharmaceuticals (Basel, Switzerland)|November 24, 2022
Integrating Mechanisms in Thrombotic Peripheral Arterial DiseaseMagdolna Nagy, Paola E J van der Meijden, Julia Glunz, et al.
Journal of Thrombosis and Haemostasis : JTH|March 6, 2026
Antibody BAY3018250 against antiplasmin enhances plasminogen activation in vitro and thrombolysis in rabbitsC J Lindo, Peng Liao, Alina Khan, et al.
Journal of Medicinal Chemistry|October 27, 2020
Design, Synthesis, and Pharmacological Characterization of a Neutral, Non-Prodrug Thrombin Inhibitor with Good Oral PharmacokineticsAlexander Hillisch, Kersten M Gericke, Swen Allerheiligen, et al.
Journal of the American Heart Association|February 8, 2023
Chymase Inhibition Resolves and Prevents Deep Vein Thrombosis Without Increasing Bleeding Time in the Mouse ModelCatherine Lapointe, Laurence Vincent, Hugo Giguère, et al.
Annals of Intensive Care|February 1, 2019
Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot studyFelix Carl Fabian Schmitt, Vasil Manolov, Jakob Morgenstern, et al.
Journal of Thrombosis and Haemostasis : JTH|April 1, 2023
Predictive value for increased activated factor XI activity in acute venous thromboembolismMagdolna Nagy, Alejandro Pallares Robles, Mayken Visser, et al.
Scientific Reports|March 9, 2019
Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient MiceJelle J Posthuma, Jens J N Posma, Rene van Oerle, et al.
Pageof 5

Showing results (21-30 of 44) with videos related to

Sort By:
Pageof 5
Investigative Radiology|April 11, 2025
Pharmacokinetics, Safety, and Dialyzability of Gadoquatrane in Patients With Impaired Renal Function: A Comprehensive Investigation Using Clinical Trial Data, Modeling and Simulation, and In Vitro DataTommaso Fadini, Gabriele Sutter, Stefan Klein, et al.
Journal of Neuroscience Research|December 31, 2016
Reduction of intracerebral hemorrhage by rivaroxaban after tPA thrombolysis is associated with downregulation of PAR-1 and PAR-2Ryuta Morihara, Toru Yamashita, Syoichiro Kono, et al.
Atherosclerosis|February 20, 2022
Effect of combining aspirin and rivaroxaban on atherosclerosis in miceSteven P Grover, Taylor Coughlin, Salma M Fleifil, et al.
Pharmaceuticals (Basel, Switzerland)|November 24, 2022
Integrating Mechanisms in Thrombotic Peripheral Arterial DiseaseMagdolna Nagy, Paola E J van der Meijden, Julia Glunz, et al.
Journal of Thrombosis and Haemostasis : JTH|March 6, 2026
Antibody BAY3018250 against antiplasmin enhances plasminogen activation in vitro and thrombolysis in rabbitsC J Lindo, Peng Liao, Alina Khan, et al.
Journal of Medicinal Chemistry|October 27, 2020
Design, Synthesis, and Pharmacological Characterization of a Neutral, Non-Prodrug Thrombin Inhibitor with Good Oral PharmacokineticsAlexander Hillisch, Kersten M Gericke, Swen Allerheiligen, et al.
Journal of the American Heart Association|February 8, 2023
Chymase Inhibition Resolves and Prevents Deep Vein Thrombosis Without Increasing Bleeding Time in the Mouse ModelCatherine Lapointe, Laurence Vincent, Hugo Giguère, et al.
Annals of Intensive Care|February 1, 2019
Acute fibrinolysis shutdown occurs early in septic shock and is associated with increased morbidity and mortality: results of an observational pilot studyFelix Carl Fabian Schmitt, Vasil Manolov, Jakob Morgenstern, et al.
Journal of Thrombosis and Haemostasis : JTH|April 1, 2023
Predictive value for increased activated factor XI activity in acute venous thromboembolismMagdolna Nagy, Alejandro Pallares Robles, Mayken Visser, et al.
Scientific Reports|March 9, 2019
Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient MiceJelle J Posthuma, Jens J N Posma, Rene van Oerle, et al.
Pageof 5